Approximately 85% of these patients exhibit a type 2‐high inflammation, with elevated levels of IL‐5, IgE, and eosinophil cationic protein (ECP) within the nasal polyp tissue, coupled with eosinophil infiltration [5, 6]. The gene discussed is RNASE3; the disease is Nasal polyposis.